John Overdeck’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

John Overdeck’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,525	Closed	-$797K	–	4716
2025 Q4	$797K	Buy	+17,525	New	+$777K	﹤0.01%	3074
2025 Q3	–	Sell	-28,350	Closed	-$956K	–	3751
2025 Q2	$956K	Buy	28,350 +6,475	+30%	+$205K	﹤0.01%	2280
2025 Q1	$696K	Buy	21,875 +500	+2%	+$19K	﹤0.01%	2366
2024 Q4	$830K	Buy	21,375 +9,125	+74%	+$383K	﹤0.01%	2291
2024 Q3	$551K	Buy	+12,250	New	+$548K	﹤0.01%	2423
2024 Q2	–	Sell	-2,525	Closed	-$115K	–	3145
2024 Q1	$115K	Sell	2,525 -1,775	-41%	-$80.8K	﹤0.01%	2818
2023 Q4	$199K	Buy	+4,300	New	+$175K	﹤0.01%	2840

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

John Overdeck's GNOM Position: Q1 2026 in Review

John Overdeck sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026, closing a stake of 17,525 shares — an estimated $797K sold.

John Overdeck first reported a position in GNOM in Q4 2023 and held it in 7 quarters. The position peaked at $956K in Q2 2025. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

John Overdeck reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
John Overdeck sold 17,525 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $797K.
John Overdeck first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and held it in 7 quarters.
John Overdeck's Global X Genomics & Biotechnology ETF position peaked at $956K in Q2 2025.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.